农业生技药品检测市场－2026-2031年预测

预计农业生技药品检测市场将从 2025 年的 20.85 亿美元成长到 2031 年的 32.21 亿美元，复合年增长率为 7.52%。

农业生技药品涵盖多种非合成材料，包括微生物接种剂（根瘤菌、菌根真菌、木霉属、芽孢桿菌属、植物促生根际细菌）、生物刺激剂（海藻提取物、腐植酸/富里酸、蛋白质水解物、亚磷酸盐）、生物肥料和生物活性土壤改良剂（生物炭、对农物质萃取物），旨在提高对农养分、对农业产生潜力的减少和传统产量。相关的检测市场提供必要的第三方分析服务，用于产品註册、功效检验、品管和功效验证，并符合欧盟肥料产品法规 (FPR 2019/1009)、美国农业部国家有机计画 (USDA NOP)、加拿大食品检验局 (CFIA) 和各国有机标准等框架。

需求主要受三个相互关联的因素所驱动。首先，对合成农药和无机肥料的监管日益严格（例如，欧盟「从农场到餐桌」战略提出的到2031年实现25%有机农田的目标，以及各国对Glyphosate和新烟碱类农药的禁令），正在推动作物管理系统向生物基系统不可逆转的转变。其次，零售商和食品加工商对永续性的要求（例如，再生有机认证和范围3脱碳承诺）日益要求生物材料的可验证使用，迫使製造商投资于严格的认证检验，以区分真正有效的产品和普通替代品。第三，生物刺激剂类别的快速扩张（目前是生物材料中成长最快的细分市场）需要先进的分析通讯协定，以便在田间条件下量化活性成分、微生物活力（CFU/g）和植物反应生物标记。

欧洲作为全球最大的有机市场，以及对新型肥料产品法规环境之一，凭藉其在农业生技药品检测的数量和价值方面持续领先全球。 2019/1009号肥料产品法规（FPR 2019/1009）的实施显着提高了安全性、稳定性和功效数据的要求，实际上强制要求对微生物群落、污染物筛检（重金属、病原体）以及多季农艺性能测试进行符合良好实验室规范（GLP）/经合组织（OECD）标准的第三方检测。国家有机认证机构（ECOCERT、Bioland、土壤协会）和私人标准机构（Demeter、BioSuisse）透过要求进行额外的残留物和微生物组影响评估，进一步提高了检测的严格程度。

微生物接种剂和生物刺激剂领域的检测需求成长最为强劲。寻求欧盟CMC-7（微生物植物生物刺激剂）或CMC-1（微生物）标籤的製造商必须提供全基因测序、16S/ITS分类鑑定、受控条件下的植物生长促进试验以及土壤/根际残留试验。同样，源自海藻萃取物和蛋白质水解物的生物刺激剂需要对信号分子（甜菜碱、多胺、油菜素甾醇）进行精确定量分析，并进行氨基酸谱分析，以支持其关于耐旱性、根系发育和养分利用效率的标籤声明。

北美正崛起为第二大土壤检测中心，这主要得益于美国农业部有机农业计划 (NOP) 认证需求的快速增长、各州层面的碳农业激励措施（例如加州健康土壤计划）以及大型作物保护公司向综合生物平台转型并迅速扩大生物材料的使用规模。食品公司再生农业倡议的推进以及对检验碳固存额度的需求，催生了对包含生物活性指标（酶活性测定、磷脂脂肪酸分析、透过 qPCR 检测微生物负荷）的土壤健康检测组合的新需求。

实验室之间的竞争日益取决于认证范围（ISO 17025、GLP、ISTA）、对时间敏感的微生物活力检测结果的交付速度，以及提供多体学表征（总体基因体学、代谢体学）以支持高级产品定位的能力。能够从单一来源提供符合欧盟食品添加剂法规 (FPR) 的完整文件或符合美国农业部生物农药和生物肥料註册要求的实验室，拥有显着的定价权。

总之，农业生技药品检测市场已从一项小众的合规职能发展成为支撑全球向永续农业转型的重要基础。随着欧洲法规结构确立全球黄金标准，以及企业加速向生技药品产品组合转型，对先进、经认证的检测服务的需求已锁定多年结构性上升趋势，且目前仍未出现饱和征兆。

本报告的主要优势：

• 深入分析：我们提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
• 竞争格局：了解全球主要企业的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
• 市场驱动因素与未来趋势：探索市场驱动因素和关键趋势及其对未来市场发展的影响。
• 可操作的建议：利用这些见解，在动态环境中做出策略决策，并开拓新的商机和收入来源。
• 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

本报告的使用范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

• 2021年至2025年的历史数据和2026年至2031年的预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 按业务板块和地区（包括国家）分類的收入和预测评估
• 公司概况（策略、产品、财务资讯）及主要发展动态

目录

第一章执行摘要

第二章 市场概览

• 市场概览
• 市场定义
• 调查范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

5. 按产品分類的农业生技药品检测市场

• 介绍
• 生物农药
• 生物肥料
• 生物刺激剂
• 其他的

6. 按应用分類的农业生技药品检测市场

• 介绍
• 现场支援
• 监管
• 分析
• 其他的

7. 按地区分類的农业生技药品检测市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第八章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 合併、收购、协议和合作
• 竞争对手仪錶板

第九章：公司简介

• Anadiag Group
• Apal Agricultural Laboratory
• Bionema Limited
• Biotecnologie BT Srl
• Eurofins Scientific SE
• i2LResearch
• Laus GmbH
• RJ Hill Laboratories Ltd
• SGS SA
• Staphyt SA

第十章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 调查方法
• 简称

Agriculture Biologicals Testing Market is forecasted to rise at a 7.52% CAGR, reaching USD 3.221 billion in 2031 from USD 2.085 billion in 2025.

Agriculture biologicals encompass a diverse portfolio of non-synthetic inputs-microbial inoculants (rhizobia, mycorrhizae, Trichoderma, Bacillus spp., PGPR), biostimulants (seaweed extracts, humic/fulvic acids, protein hydrolysates, phosphites), biofertilizers, and bioactive soil amendments (biochar, compost extracts)-designed to enhance nutrient uptake, stress resilience, and yield potential while reducing reliance on conventional agrochemicals. The associated testing market provides essential third-party analytical services for product registration, label claims verification, quality control, and efficacy demonstration under schemes such as EU Fertilising Products Regulation (FPR 2019/1009), USDA NOP, Canada CFIA, and various national organic standards.

Demand is structurally propelled by three interlocking forces. First, tightening regulatory restrictions on synthetic pesticides and mineral fertilizers-exemplified by the EU Farm-to-Fork 25 % organic land target by 2031 and national bans on glyphosate and neonicotinoids-are creating an irreversible push toward biologically based crop management systems. Second, retailer and food-processor sustainability mandates (e.g., Regenerative Organic Certified, Scope 3 decarbonization commitments) increasingly require verifiable use of biological inputs, driving manufacturers to invest in rigorous, accredited testing to differentiate genuine efficacy from commodity offerings. Third, the rapid expansion of the biostimulant category-now the fastest-growing segment within biologicals-necessitates sophisticated analytical protocols for quantifying active compounds, microbial viability (CFU/g), and plant-response biomarkers under field conditions.

Europe continues to dominate global agriculture biologicals testing volume and value, benefiting from the continent's position as both the largest organic market and the most stringent regulatory environment for novel fertilizing products. The implementation of FPR 2019/1009 has dramatically raised the bar for safety, stability, and efficacy data requirements, effectively mandating third-party GLP/OECD-compliant testing for microbial consortia, contaminant screening (heavy metals, pathogens), and multi-season agronomic performance trials. National organic certification bodies (ECOCERT, Bioland, Soil Association) and private standards (Demeter, BioSuisse) impose additional residue and microbiome-impact assessments that further deepen testing intensity.

The microbial inoculant and biostimulant segments are experiencing the strongest testing demand growth. Manufacturers pursuing EU CMC-7 (microbial plant biostimulant) or CMC-1 (micro-organism) claims must now provide whole-genome sequencing, taxonomic identification via 16S/ITS, plant-growth promotion assays under controlled conditions, and persistence studies in soil/rhizosphere. Similarly, seaweed-extract and protein-hydrolysate biostimulants require precise quantification of signaling molecules (betaines, polyamines, brassinosteroids) and amino-acid profiling to support label claims on drought tolerance, root development, or nutrient-use efficiency.

North America is emerging as the second major testing hub, driven by accelerating USDA NOP accreditation needs, state-level carbon farming incentives (California Healthy Soils Program), and the rapid scale-up of biologicals by major crop-protection players pivoting toward integrated biological platforms. The convergence of regenerative agriculture initiatives from food companies and the need for verifiable carbon-sequestration credits are creating new demand for soil health testing panels that include biological activity metrics (enzyme assays, PLFA, qPCR microbial abundance).

Competitive differentiation among testing laboratories increasingly hinges on accreditation scope (ISO 17025, GLP, ISTA), speed-to-result for time-sensitive microbial viability testing, and ability to offer multi-omic characterization (metagenomics, metabolomics) that supports premium product positioning. Laboratories capable of delivering fully compliant EU FPR dossiers or USDA biopesticide/biofertilizer registration packages under one roof command significant pricing power.

In conclusion, the agriculture biologicals testing market has evolved from a niche compliance function into a critical enabling infrastructure for the global transition to sustainable intensification. With Europe's regulatory framework setting the global gold standard and an accelerating corporate shift toward biological portfolios, demand for sophisticated, accredited testing services is locked into a multi-year structural uptrend that shows no sign of saturation.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Agriculture Biologicals Testing Market Segmentation:

BY PRODUCT

• Biopesticides
• Biofertilizers
• Biostimulants
• Others

BY APPLICATION

• Field Support
• Regulatory
• Analytical
• Others

BY GEOGRAPHY

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AGRICULTURE BIOLOGICALS TESTING MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Biopesticides
• 5.3. Biofertilizers
• 5.4. Biostimulants
• 5.5. Others

6. AGRICULTURE BIOLOGICALS TESTING MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Field Support
• 6.3. Regulatory
• 6.4. Analytical
• 6.5. Others

7. AGRICULTURE BIOLOGICALS TESTING MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. India
  • 7.6.3. Japan
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Anadiag Group
• 9.2. Apal Agricultural Laboratory
• 9.3. Bionema Limited
• 9.4. Biotecnologie B.T. Srl
• 9.5. Eurofins Scientific SE
• 9.6. i2LResearch
• 9.7. Laus GmbH
• 9.8. RJ Hill Laboratories Ltd
• 9.9. SGS SA
• 9.10. Staphyt S.A.

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key Benefits for the Stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations